152 related articles for article (PubMed ID: 12445417)
1. Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.
Heller J; Schepke M; Neef M; Woitas R; Rabe C; Sauerbruch T
J Hepatol; 2002 Dec; 37(6):767-72. PubMed ID: 12445417
[TBL] [Abstract][Full Text] [Related]
2. Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.
Kemp W; Krum H; Colman J; Bailey M; Yandle T; Richards M; Roberts S
Liver Int; 2007 Nov; 27(9):1232-9. PubMed ID: 17919235
[TBL] [Abstract][Full Text] [Related]
3. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
4. Urotensin II levels are an important marker for the severity of portal hypertension in children.
Pawar R; Kemp W; Roberts S; Krum H; Yandle T; Hardikar W
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):88-92. PubMed ID: 21694541
[TBL] [Abstract][Full Text] [Related]
5. Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.
Trebicka J; Krag A; Gansweid S; Schiedermaier P; Strunk HM; Fimmers R; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Spengler U
PLoS One; 2013; 8(12):e83341. PubMed ID: 24386183
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis.
Romanelli RG; Laffi G; Vizzutti F; Del Bene R; Marra F; Caini P; Guerra CT; La Villa G; Barletta G
Dig Liver Dis; 2011 Apr; 43(4):314-8. PubMed ID: 20943446
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
9. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension.
Liu D; Chen J; Wang J; Zhang Z; Ma X; Jia J; Wang Y
Int J Mol Med; 2010 Jun; 25(6):845-51. PubMed ID: 20428787
[TBL] [Abstract][Full Text] [Related]
11. TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes.
Busk TM; Bendtsen F; Nielsen HJ; Jensen V; Brünner N; Møller S
Scand J Gastroenterol; 2014 Sep; 49(9):1103-10. PubMed ID: 25048331
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites.
Martinet JP; Legault L; Cernacek P; Roy L; Dufresne MP; Spahr L; Fenyves D; Pomier-Layrargues G
J Hepatol; 1996 Nov; 25(5):700-6. PubMed ID: 8938548
[TBL] [Abstract][Full Text] [Related]
13. Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
Geilswijk M; Thomsen KL; Pedersen EB; Vilstrup H; Grønbæk H
Scand J Gastroenterol; 2015 Apr; 50(4):454-61. PubMed ID: 25637473
[TBL] [Abstract][Full Text] [Related]
14. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion.
Mortensen C; Karlsen S; Grønbæk H; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F
Liver Int; 2013 Oct; 33(9):1309-15. PubMed ID: 23763259
[TBL] [Abstract][Full Text] [Related]
15. Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension.
Trebicka J; Wix C; von Heydebrand M; Hittatiya K; Reiberger T; Klein S; Schierwagen R; Kristiansen G; Peck-Radosavljevic M; Fischer HP; Møller S; Bendtsen F; Krag A; Sauerbruch T
Liver Int; 2015 Apr; 35(4):1393-402. PubMed ID: 24912856
[TBL] [Abstract][Full Text] [Related]
16. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
17. Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function.
Yang YY; Lin HC; Lee WC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD
J Gastroenterol Hepatol; 2003 Oct; 18(10):1156-61. PubMed ID: 12974902
[TBL] [Abstract][Full Text] [Related]
18. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
Piecha F; Paech D; Sollors J; Seitz HK; Rössle M; Rausch V; Mueller S
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G179-G187. PubMed ID: 29051188
[TBL] [Abstract][Full Text] [Related]
19. Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension.
Bakr AM; Abdalla AF; El-Marsafawy H; Abu-Hashem I; El-Regal ME; Amer T; Abdel-Khalik MK; Mostafa H; A-Kader HH
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):149-53. PubMed ID: 12187289
[TBL] [Abstract][Full Text] [Related]
20. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
